DCTH News and Press, Delcath Systems Inc. From 03/26/24

2024-03-26 07:33:09 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

2024-03-25 13:22:47 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data...

2024-03-24 08:01:00 ET Westport Fuel Systems ( WPRT ) is set to report its Q4 earnings on Monday after the closing bell. The stock, which has dropped about 24% over a 12-month period, has received a Buy rating from Wall Street analysts, while Seeking Alpha's Quant Rating system has ...

Delcath Systems Closes $7 Million Private Placement PR Newswire NEW YORK , March 20, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, confirmed the closi...

Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call PR Newswire NEW YORK , March 19, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and m...

2024-03-18 17:25:15 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Read the full article ...

Delcath Systems Appoints Martha S. Rook as Chief Operating Officer PR Newswire NEW YORK , March 18, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and met...

2024-03-15 09:01:04 ET More on Delcath Systems Delcath Systems announces CMS established product-specific J-code for HEPZATO Delcath launches Hepzato Kit in US for uveal melanoma Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data ...

Delcath Systems Announces $7 Million Private Placement PR Newswire NEW YORK , March 15, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today an...